A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers

Clinical trial NCT06698861 · COMPLETED

Trial details

NCT number: NCT06698861
Sponsor: PharmaEssentia
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

PK in Healthy Volunteers

Start date: 2024-08-19
Primary completion: 2025-02-06
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.